Screening Women With Prior HPV for Anal Neoplasia
The Effectiveness of Screening Women With Lower Genital Tract Neoplasia or Cancers for Anal Cancer Precursors
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 35 Years and older
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
Not stated in the study description — ask the study team about visits and procedures.
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study looks at ways to screen for abnormal cells in the anus that could become cancer. It is for women age 35 or older who do not have HIV and have had certain HPV-related cell changes or cancers in the genital area.
The goal of this single arm trial is to prospectively evaluate screening methods for anal cancer precursors in HIV uninfected women with a history of lower genital tract neoplasias and cancers.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- Women with serious HPV-related cell changes confirmed by a tissue test in the cervix, vagina, or vulva (outer genitals), or a history of cancer in these areas that had not spread to distant parts of the body.
- A documented negative HIV test.
- Age 35 or older.
- Seen in the Mount Sinai Health System or the Harris Health System in Houston.
- Speak English or Spanish.
Who can't join
- The listed rule is unclear: “prior history or high resolution anoscopy.” Anoscopy is a close-up exam of the anus. Ask the study team what this rule means.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Inclusion Criteria: * Women with a history of pathologically proven high-grade genital HPV-associated neoplastic disease (cervical intraepithelial neoplasia 2+, vulvar intraepithelial neoplasia 2+, or vaginal intraepithelial neoplasia 2+, or history of non-metastatic cervical, vaginal or vulvar cancer) * Documented HIV seronegativity * Aged 35 years and older * Seen in the Mount Sinai Health System (MSHS) or the Harris Health System (HHS) in Houston * English or Spanish speaking Exclusion Criteria: • prior history or high resolution anoscopy
Study sites (3)
NY
- Icahn School of Medicine at Mount Sinai · New York, NY 10029Daniela Solis · Study contact · 305-775-2140 · daniela.solis@mountsinai.orgKeith Sigel, MD PHD MPH · Principal investigatorMore trials in New York
SC
- Medical University of South Carolina · Charleston, SC 29425Talia Wahl · Study contact · wahlt@musc.eduAshish Deshmukh, PhD · Principal investigatorMore trials in Charleston
TX
- University of Texas M D Anderson Cancer Center · Houston, TX 77030Elizabeth Chiao · Study contact · EYChiao@mdanderson.orgElizabeth Chiao, MD · Principal investigatorMore trials in Houston